Georgia Wells / Wall Street Journal:
A look at OpenAI-backed Red Queen Bio, an AI biosecurity startup with $36M raised to design antibody drugs against pathogens, including AI-enabled bioweapons — Red Queen Bio is using artificial intelligence to design antibody drugs for novel pathogens—before future AI systems create them
